ENLIVEN
Live / Registered — Registered — international registration renewed (as of 05 Sept 2024)
What this means for you
Registered since 05 Dec 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Dec 2027: the §71 ten-year affidavit of use).
Record
- Serial number
- 79166998
- Registration number
- 5348138
- Mark type
- Word mark
- Filed
- 23 Mar 2015
- Published for opposition
- 19 Sept 2017
- Registered
- 05 Dec 2017
- Next maintenance filing
- §71 ten-year affidavit of use, due by 05 Dec 2027 (grace period to 05 Jun 2028)
- Attorney of record
- Jacqueline G. Lendvai
Goods and services
- Class 042 — Scientific and technological services: [ Conducting of clinical studies and trials for others in the field of pharmaceuticals; ] providing medical and scientific research information on clinical studies and trials of pharmaceuticals
Owner
- DAIICHI SANKYO COMPANY, LIMITED, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Tokyo, JP
- DAIICHI SANKYO COMPANY, LIMITED, Tokyo, JP
Prosecution history
- 02 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 Sept 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 20 Aug 2025 — GENERIC MADRID TRANSACTION SENT TO IB
- 20 Aug 2025 — GENERIC MADRID TRANSACTION CREATED
- 05 May 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 10 Apr 2025 — INTERNATIONAL REGISTRATION RENEWED
- 05 Sept 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 05 Sept 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 03 Sept 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Nov 2023 — TEAS SECTION 71 & 15 RECEIVED
- 05 Dec 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 03 Jul 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 May 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Mar 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 19 Mar 2018 — FINAL DISPOSITION PROCESSED